Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the visual outcome, number of injections and visits, and the effect of mental
status of a treat and extend regimen in managing neovascular age-related macular degeneration
with intravitreal ranibizumab.